Sutro Biopharma, Inc. (STRO)
24.45
-0.09
(-0.37%)
USD |
NASDAQ |
Mar 12, 16:00
23.01
-1.44
(-5.89%)
Pre-Market: 08:31
Sutro Biopharma Total Liabilities (Quarterly) : 296.93M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| GT Biopharma, Inc. | 2.319M |
| Rhythm Pharmaceuticals, Inc. | 342.12M |
| Crinetics Pharmaceuticals, Inc. | 143.41M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 209.66M |
| Shareholders Equity (Quarterly) | -87.27M |
| Debt to Equity Ratio | -2.607 |
| Current Ratio | 2.533 |
| Net Debt Paydown Yield | -10.04% |